Advertisement
Canada markets open in 1 minute

  • S&P/TSX

    22,011.62
    +42.38 (+0.19%)
     

  • S&P 500

    5,116.17
    +16.21 (+0.32%)
     

  • DOW

    38,386.09
    +146.43 (+0.38%)
     

  • CAD/USD

    0.7282
    -0.0040 (-0.54%)
     

  • CRUDE OIL

    82.42
    -0.21 (-0.25%)
     

  • Bitcoin CAD

    86,000.88
    -925.06 (-1.06%)
     

  • CMC Crypto 200

    1,305.62
    -33.45 (-2.50%)
     

  • GOLD FUTURES

    2,315.20
    -42.50 (-1.80%)
     

  • RUSSELL 2000

    2,016.03
    +14.03 (+0.70%)
     

  • 10-Yr Bond

    4.6590
    +0.0450 (+0.98%)
     

  • NASDAQ futures

    17,833.00
    -71.25 (-0.40%)
     

  • VOLATILITY

    15.01
    +0.34 (+2.32%)
     

  • FTSE

    8,176.04
    +29.01 (+0.36%)
     

  • NIKKEI 225

    38,405.66
    +470.90 (+1.24%)
     

  • CAD/EUR

    0.6801
    -0.0023 (-0.34%)
     
MARKETS LIVE BLOG:

STOCK FUTURES HIT PAUSE WITH FED IN FOCUS, AMAZON EARNINGS ON DECK

Prospect of rate cuts has fallen dramatically since the start of 2024, helping drive up Treasury yields

Stocks in play: Oncolytics Biotech® Inc.

Baystreet.ca

Announced the submission of a Type C meeting request to the FDA. This meeting aims to discuss the Company's planned registration-enabling trial for pelareorep in HR+/HER2- metastatic breast cancer. Oncolytics Biotech® Inc. shares T.ONC are trading down $0.05 at $1.52.

Read: